Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
According to new Market Research Report Published by P&S Market Research
Published Date: June 2015 Number of Pages: 124
Write to: [email protected]
(or)
Call US/ Canada toll-free:1-888-778-7886
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
P&S Market Research releases a new research report with market overview, trends, DRO analysis, market segmentation, market size, share, forecast, porter analysis, recent developments, competitive scenario and top competitor profiles in:
Global Industry Insight: Human Insulin Market development and demand forecast to 2020
For more information visit: https://www.psmarketresearch.com/market-analysis/human-insulin-market
The global human insulin market is expected to witness double digit growth during the period 2015 to 2020 to reach $48,487.7 million value by 2020. The global human insulin market is being driven by increasing prevalence of diabetic population, and rise in aging population. Diabetes is a chronic and non-communicable disease, and its global prevalence is increasing enormously. Rising prevalence of obesity, rising awareness about diabetic care, and technological advancement in insulin delivery devices are some of the factors driving the growth of the global human insulin market.
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
Growing demand of biosimilar drugs, due to its cost effectiveness, pose an opportunity for the growth of the human insulin market. In addition, increasing usage of insulin pens for the administration of insulin helps to inject the accurate dose of insulin at a time. However, high insulin analog cost and strict regulatory requirements for approval of human insulin are inhibiting the growth of the global human insulin market
Request for Report Sample: https://www.psmarketresearch.com/enquiry-form.php?enqid=176&title=Report%20sample
Increasing prevalence of diabetes, increasing number of geriatric population, rising prevalence of obesity and increasing R&D investment for more effective insulin are driving the growth of the human insulin market in North America. The North American human insulin market is expected to grow by a CAGR of 11.8% during the period 2015 to 2020. In Europe, according to International Diabetic Federation in 2013, approximately 52 million people were suffering from diabetes in Europe. The European human insulin market is expected to grow by a CAGR of 12.6% during the period 2015 to 2020. Thus, increasing prevalence of diabetes would increase the usage of human insulin. Also, in Asia Pacific region, several government initiatives are implemented to create awareness about prevention and treatment of diabetes. The government is also taking initiatives to improve healthcare infrastructure and provide treatment in rural areas. In Asia-Pacific, the human insulin market is expected to witness CAGR of 13.9% during the period 2015 to 2020.
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
Growing demand of biosimilar drugs, due to its cost effectiveness, pose an opportunity for the growth of the human insulin market. In addition, increasing usage of insulin pens for the administration of insulin helps to inject the accurate dose of insulin at a time. However, high insulin analog cost and strict regulatory requirements for approval of human insulin are inhibiting the growth of the global human insulin market
Request for Report Sample: https://www.psmarketresearch.com/enquiry-form.php?enqid=176&title=Report%20sample
Increasing prevalence of diabetes, increasing number of geriatric population, rising prevalence of obesity and increasing R&D investment for more effective insulin are driving the growth of the human insulin market in North America. The North American human insulin market is expected to grow by a CAGR of 11.8% during the period 2015 to 2020.
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
In Europe, according to International Diabetic Federation in 2013, approximately 52 million people were suffering from diabetes in Europe. The European human insulin market is expected to grow by a CAGR of 12.6% during the period 2015 to 2020. Thus, increasing prevalence of diabetes would increase the usage of human insulin. Also, in Asia Pacific region, several government initiatives are implemented to create awareness about prevention and treatment of diabetes. The government is also taking initiatives to improve healthcare infrastructure and provide treatment in rural areas. In Asia-Pacific, the human insulin market is expected to witness CAGR of 13.9% during the period 2015 to 2020.
Enquiry Before Buying: https://www.psmarketresearch.com/enquiry-form.php?enqid=176&title=Enquiry%20before%20purchase
The global human insulin market has a fragmented structure with large number of companies operating in the market. The key players in the human insulin market include Sanofi, Novo Nordisk A/S, Eli Lilly and Company, GlaxoSmithKline Plc, Pfizer, Inc., Merck & Co., and Julphar.
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
Human Insulin Market Segmentation
• Human Insulin Market by type
• Traditional human insulin
• Modern human insulin
Traditional Human Insulin Market by type
• Short acting human insulin
• Intermediate acting human insulin
• Premixed human insulin
Modern Human Insulin Market by type
• Long acting human insulin
• Rapid acting human insulin
• Premixed human insulin
Human Insulin Market by Brand
• Lantus
• Novorapid
• Humalog
• Novomix
• Levemir
• Apidar
• Humulin
• Insuman
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
Geographical Segmentation
• Human Insulin Market by Region
• North America
– The U.S.
– Canada
• Europe
– Germany
– France
– The U.K.
• Asia-Pacific
– India
– China
– Japan
• Rest of the World (ROW)
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
Table of Content Chapter 1 Research Scope and Methodology
1.1 Market Definition
1.2 Market Breakdown by Different Categories
1.3 Market Breakdown by Geography
1.4 Research Methodology and Sources
Chapter 2 Executive Summary
2.1 Key Findings
2.2 Research Summary
Chapter 3 Market Outlook
3.1 Introduction
3.2 Trends in the Market
3.2.1 Rising usage of insulin pen for the administration of human insulin
3.3 Opportunities in the Market
3.3.1 Growing demand of biosimilar drugs due to its cost effectiveness
3.4 Factors Driving the Market and its Impact on Market Forecast
For more information visit: https://www.psmarketresearch.com/market-analysis/human-insulin-market
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
3.4.1 Rising aging population
3.4.2 Increasing diabetic population
3.4.3 Rising prevalence of obesity
3.4.4 Technological advancement in drug delivery devices
3.4.5 Increasing awareness about diabetic care
3.4.6 Impact analysis of drivers on market forecast
3.5 Factors Hindering the Market and its Impact on Market Forecast
3.5.1 High insulin analogue cost
3.5.2 Strict regulatory requirements for approval of human insulin
3.5.3 Impact analysis of restraints on market forecast
Chapter 4 Global Market Size and Forecasts (2011 – 2020)
4.1 Global Market Breakdown by Type
4.2 Global Tradition Human Insulin Market Breakdown by Type
4.3 Global Modern Human Insulin Market Breakdown by Type
4.4 Global Market Breakdown by Region
Chapter 5 Global Market Breakdown by Type
5.1 Traditional Human Insulin Market Breakdown by Region
5.2 Modern Human Insulin Market Breakdown by Region
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
Chapter 6 Global Traditional Human Insulin Market Breakdown by Type
6.1 Short Acting Human Insulin Market Breakdown by Region
6.2 Intermediate Acting Human Insulin Market Breakdown by Region
6.3 Premixed Human Insulin Market Breakdown by Region
Chapter 7 Global Modern Human Insulin Market Breakdown by Type
7.1 Long Acting Human Insulin Market Breakdown by Region
7.2 Rapid Acting Human Insulin Market Breakdown by Region
7.3 Premixed Human Insulin Market Breakdown by Region
Chapter 8 Global Market Breakdown by Brand
Chapter 9 Global Market Breakdown by Region
9.1 North America Market Breakdown by Country, Technology, End Users and Application
9.1.1 The U.S. market breakdown by type of human insulin, by type of traditional human insulin,
and by type of modern human insulin
9.1.2 Canada market breakdown by type of human insulin, by type of traditional human insulin,
and by type of modern human insulin
9.2 Europe Market Breakdown by Country, Technology, End Users and Application
9.2.1 Germany market breakdown by type of human insulin, by type of traditional human insulin,
and by type of modern human insulin
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
9.2.2 The U.K. market breakdown by type of human insulin, by type of traditional human insulin,
and by type of modern human insulin
9.2.3 France market breakdown by type of human insulin, by type of traditional human insulin,
and by type of modern human insulin
9.3 Asia-Pacific Market Breakdown by Country, Technology, End Users and Application
9.3.1 Japan market breakdown by type of human insulin, by type of traditional human insulin, and
by type of modern human insulin
9.3.2 China market breakdown by type of human insulin, by type of traditional human insulin, and
by type of modern human insulin
9.3.3 India market breakdown by type of human insulin, by type of traditional human insulin, and
by type of modern human insulin
9.4 Rest of the World (RoW) Market Breakdown by Type, by Type of Traditional human insulin
and by Type of Modern Human Insulin
Chapter 10 Competitive Analysis and Market Share
10.1 Porter's Five Forces of Competitive Position Analysis
10.1.1 Bargaining Power of Buyers
10.1.2 Bargaining Power of Suppliers
10.1.3 Threat of New Entrants
For more information visit: https://www.psmarketresearch.com/market-analysis/human-insulin-market
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
10.1.4 Intensity of Rivalry
10.1.5 Threat of Substitutes
10.2 Competitive Positioning of Key Competitors
Chapter 11 Company Profiles
11.1 Biocon Ltd.
11.1.1 Business Overview
11.1.2 Products and Services
11.1.3 Recent Developments
11.1.4 Key P&L Metrics
11.2 TonghuaDongbao Pharmaceuticals Co., Ltd
11.2.1 Business Overview
11.2.2 Products and Services
11.2.3 Recent Developments
11.2.4 Key P&L Metrics
11.3 ADOCIA
11.3.1 Business Overview
11.3.2 Products and Services
Request for Report Sample: https://www.psmarketresearch.com/enquiry-form.php?enqid=176&title=Report%20sample
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
11.4.2 Products and Services
11.4.3 Recent Developments
11.4.4 Key P&L Metrics
11.5 Julphar
11.5.1 Business Overview
11.5.2 Products and Services
11.5.3 Recent Developments
11.5.4 Key P&L Metrics
11.6 Pfizer, Inc.
11.6.1 Business Overview
11.6.2 Products and Services
11.6.3 Recent Developments
11.6.4 Key P&L Metrics
11.7 Bristol-Myers Squibb Company
11.7.1 Business Overview
11.7.2 Products and Services
11.7.3 Recent Developments
For more information visit: https://www.psmarketresearch.com/market-analysis/human-insulin-market
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
11.8.4 Key P&L Metrics
11.9 Oramed Pharmaceuticals, Inc.
11.9.1 Business Overview
11.9.2 Products and Services
11.9.3 Recent Developments
11.9.4 Key P&L Metrics
11.10 Novo Nordisk A/S
11.10.1 Business Overview
11.10.2 Products and Services
11.10.3 Recent Developments
11.10.4 Key P&L Metrics
11.11 Eli Lilly and Company
11.11.1 Business Overview
11.11.2 Products and Services
11.11.3 Recent Developments
11.11.4 Key P&L Metrics
11.12 Sanofi
Request for Report Sample: https://www.psmarketresearch.com/enquiry-form.php?enqid=176&title=Report%20sample
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
11.12.1 Business Overview
11.12.2 Products and Services
11.12.3 Recent Developments
11.12.4 Key P&L Metrics
Chapter 12 Appendix
12.1 List of Abbreviations
List of Figures
FIG. 1 Production of human insulin
FIG. 2 Aging population in major regions, in % (2000 – 2050)
FIG. 3 Number of people suffering from diabetes aged 20-79 years, 2013 and 2035
FIG. 4 Prevalence of overweight men aged 30 and above, in % (2005 and 2015)
FIG. 5 Prevalence of overweight women aged 30 and above, in % (2005 and 2015)
FIG. 6 Global human insulin market share by type (2014)
FIG. 7 Global traditional human insulin market share by type (2014)
FIG. 8 Global modern human insulin market share by type (2014)
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
FIG. 9 Global human insulin market share by region (2014)
FIG. 10 Global traditional human insulin market share by region (2014)
FIG. 11 Global modern human insulin market share by region (2014)
FIG. 12 Global short acting human insulin market share by region (2014)
FIG. 13 Global intermediate acting human insulin market share by region (2014)
FIG. 14 Global premixed human insulin market share by region (2014)
FIG. 15 Global long acting human insulin market share by region (2014)
FIG. 16 Global rapid acting human insulin market share by region (2014)
FIG. 17 Global premixed human insulin market share by region (2014)
FIG. 18 Global human insulin market share by brand (2014)
FIG. 19 North American human insulin market share by country (2014)
FIG. 20 North America human insulin market share by type (2014)
FIG. 21 North America traditional human insulin market share by type (2014)
FIG. 22 North America modern human insulin market share by type (2014)
FIG. 23 The U.S. human insulin market share by type (2014)
FIG. 24 The U.S. traditional human insulin market share by type (2014)
FIG. 25 The U.S. modern human insulin market share by type (2014)
For more information visit: https://www.psmarketresearch.com/market-analysis/human-insulin-market
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
FIG. 26 Canada human insulin market share by type (2014)
FIG. 27 Canada traditional human insulin market share by type (2014)
FIG. 28 Canada modern human insulin market share by type (2014)
FIG. 29 Europe human insulin market share by country (2014)
FIG. 30 Europe human insulin market share by type (2014)
FIG. 31 Europe traditional human insulin market share by type (2014)
FIG. 32 Europe modern human insulin market share by type (2014)
FIG. 33 Germany human insulin market share by type (2014)
FIG. 34 Germany traditional human insulin market share by type (2014)
FIG. 35 Germany modern human insulin market share by type (2014)
FIG. 36 The U.K. human insulin market share by type (2014)
FIG. 37 The U.K. traditional human insulin market share by type (2014)
FIG. 38 The U.K. modern human insulin market share by type (2014)
FIG. 39 France human insulin market share by type (2014
FIG. 40 France traditional human insulin market share by type (2014)
FIG. 41 France modern human insulin market share by type (2014)
FIG. 42 Asia-Pacific human insulin market share by country (2014)
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
FIG. 43 Asia-Pacific human insulin market share by type (2014)
FIG. 44 Asia-Pacific traditional human insulin market share by type (2014)
FIG. 45 Asia-Pacific modern human insulin market share by type (2014)
FIG. 46 Japan human insulin market share by type (2014)
FIG. 47 Japan traditional human insulin market share by type (2014)
FIG. 48 Japan modern human insulin market share by type (2014)
FIG. 49 China human insulin market share by type (2014)
FIG. 50 China traditional human insulin market share by type (2014)
FIG. 51 China modern human insulin market share by type (2014)
FIG. 52 India human insulin market share by type (2014)
FIG. 53 India traditional human insulin market share by type (2014)
FIG. 54 India modern human insulin market share by type (2014)
FIG. 55 Rest of the World human insulin market share by type (2014)
FIG. 56 Rest of the World traditional human insulin market share by type (2014)
FIG. 57 Rest of the World modern human insulin market share by type (2014)
FIG. 58 Porter’s five forces of competitive position analysis
FIG. 59 Competitive positioning of key competitors
Request for Report Sample: https://www.psmarketresearch.com/enquiry-form.php?enqid=176&title=Report%20sample
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
List of Tables
TABLE 1 Specific primary and secondary sources used for this publication
TABLE 2 Global human insulin market snapshot (2015 and 2020)
TABLE 3 Drivers for the market: Impact analysis
TABLE 4 Restraints for the market: Impact analysis
TABLE 5 Global human insulin market breakdown by type, $m (2011 – 2014)
TABLE 6 Global human insulin market breakdown by type, $m (2015 – 2020)
TABLE 7 Global traditional human insulin market breakdown by type, $m (2011 – 2014)
TABLE 8 Global traditional human insulin market breakdown by type, $m (2015 – 2020)
TABLE 9 Global modern human insulin market breakdown by type, $m (2011 – 2014)
TABLE 10 Global modern human insulin market breakdown by type, $m (2015 – 2020)
TABLE 11 Global human insulin market breakdown by region, $m (2011 – 2014)
TABLE 12 Global human insulin market breakdown by region, $m (2015 – 2020)
TABLE 13 Global traditional human insulin market breakdown by region, $m (2011 – 2014)
TABLE 14 Global traditional human insulin market breakdown by region, $m (2015 – 2020)
TABLE 15 Global modern human insulin market breakdown by region, $m (2011 – 2014)
For more information visit: https://www.psmarketresearch.com/market-analysis/human-insulin-market
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
TABLE 16 Global modern human insulin market breakdown by region, $m (2015 – 2020)
TABLE 17 Global short acting human insulin market breakdown by region, $m (2011 – 2014)
TABLE 18 Global short acting human insulin market breakdown by region, $m (2015 – 2020)
TABLE 19 Global intermediate acting human insulin market breakdown by region, $m (2011 – 2014)
TABLE 20 Global intermediate acting human insulin market breakdown by region, $m (2015 – 2020)
TABLE 21 Global premixed human insulin market breakdown by region, $m (2011 – 2014)
TABLE 22 Global premixed human insulin market breakdown by region, $m (2015 – 2020)
TABLE 23 Global long acting human insulin market breakdown by region, $m (2011 – 2014)
TABLE 24 Global long acting human insulin market breakdown by region, $m (2015 – 2020)
TABLE 25 Global rapid acting human insulin market breakdown by region, $m (2011 – 2014)
TABLE 26 Global rapid acting human insulin market breakdown by region, $m (2015 – 2020)
TABLE 27 Global premixed human insulin market breakdown by region, $m (2011 – 2014)
TABLE 28 Global premixed human insulin market breakdown by region, $m (2015 – 2020)
TABLE 29 Some of the human insulin drugs in pipeline by various companies
TABLE 30 Global human insulin market breakdown by brand, $m (2011 – 2014)
TABLE 31 Global human insulin market breakdown by brand, $m (2015 – 2020)
TABLE 32 North America human insulin market breakdown by country, $m (2011 – 2014)
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
TABLE 33 North America human insulin market breakdown by country, $m (2015 – 2020)
TABLE 34 North America human insulin market breakdown by type, $m (2011 – 2014)
TABLE 35 North America human insulin market breakdown by type, $m (2015 – 2020)
TABLE 36 North America traditional human insulin market breakdown by type, $m (2011 – 2014)
TABLE 37 North America traditional human insulin market breakdown by type, $m (2015 – 2020)
TABLE 38 North America modern human insulin market breakdown by type, $m (2011 – 2014)
TABLE 39 North America modern human insulin market breakdown by type, $m (2015 – 2020)
TABLE 40 The U.S. human insulin market breakdown by type, $m (2011 – 2014)
TABLE 41 The U.S. human insulin market breakdown by type, $m (2015 – 2020)
TABLE 42 The U.S. traditional human insulin market breakdown by type, $m (2011 – 2014)
TABLE 43 The U.S. traditional human insulin market breakdown by type, $m (2015 – 2020)
TABLE 44 The U.S. modern human insulin market breakdown by type, $m (2011 – 2014)
TABLE 45 The U.S. modern human insulin market breakdown by type, $m (2015 – 2020)
TABLE 46 Canada human insulin market breakdown by type, $m (2011 – 2014)
TABLE 47 Canada human insulin market breakdown by type, $m (2015 – 2020)
TABLE 48 Canada traditional human insulin market breakdown by type, $m (2011 – 2014)
TABLE 49 Canada traditional human insulin market breakdown by type, $m (2015 – 2020)
TABLE 50 Canada modern human insulin market breakdown by type, $m (2011 – 2014)
TABLE 51 Canada modern human insulin market breakdown by type, $m (2015 – 2020)
TABLE 52 Europe human insulin market breakdown by country, $m (2011 – 2014)
TABLE 53 Europe human insulin market breakdown by country, $m (2015 – 2020)
TABLE 54 Europe human insulin market breakdown by type, $m (2011 – 2014)
TABLE 55 Europe human insulin market breakdown by type, $m (2015 – 2020)
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
TABLE 56 Europe traditional human insulin market breakdown by type, $m (2011 – 2014)
TABLE 57 Europe traditional human insulin market breakdown by type, $m (2015 – 2020)
TABLE 58 Europe modern human insulin market breakdown by type, $m (2011 – 2014)
TABLE 59 Europe modern human insulin market breakdown by type, $m (2015 – 2020)
TABLE 60 Germany human insulin market breakdown by type, $m (2011 – 2014)
TABLE 61 Germany human insulin market breakdown by type, $m (2015 – 2020)
TABLE 62 Germany traditional human insulin market breakdown by type, $m (2011 – 2014)
TABLE 63 Germany traditional human insulin market breakdown by type, $m (2015 – 2020)
TABLE 64 Germany modern human insulin market breakdown by type, $m (2011 – 2014)
TABLE 65 Germany modern human insulin market breakdown by type, $m (2015 – 2020)
TABLE 66 The U.K. human insulin market breakdown by type, $m (2011 – 2014)
TABLE 67 The U.K. human insulin market breakdown by type, $m (2015 – 2020)
TABLE 68 The U.K. traditional human insulin market breakdown by type, $m (2011 – 2014)
TABLE 69 The U.K. traditional human insulin market breakdown by type, $m (2015 – 2020)
TABLE 70 The U.K. modern human insulin market breakdown by type, $m (2011 – 2014)
TABLE 71 The U.K. modern human insulin market breakdown by type, $m (2015 – 2020)
TABLE 72 France human insulin market breakdown by type, $m (2011 – 2014)
TABLE 73 France human insulin market breakdown by type, $m (2015 – 2020)
TABLE 74 France traditional human insulin market breakdown by type, $m (2011 – 2014)
TABLE 75 France traditional human insulin market breakdown by type, $m (2015 – 2020)
TABLE 76 France modern human insulin market breakdown by type, $m (2011 – 2014)
TABLE 77 France modern human insulin market breakdown by type, $m (2015 – 2020)
TABLE 78 Asia-Pacific human insulin market breakdown by country, $m (2011 – 2014)
TABLE 79 Asia-Pacific human insulin market breakdown by country, $m (2015 – 2020) https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
TABLE 79 Asia-Pacific human insulin market breakdown by country, $m (2015 – 2020)
TABLE 80 Asia-Pacific human insulin market breakdown by type, $m (2011 – 2014)
TABLE 81 Asia-Pacific human insulin market breakdown by type, $m (2015 – 2020)
TABLE 82 Asia-Pacific traditional human insulin market breakdown by type, $m (2011 – 2014)
TABLE 83 Asia-Pacific traditional human insulin market breakdown by type, $m (2015 – 2020)
TABLE 84 Asia-Pacific modern human insulin market breakdown by type, $m (2011 – 2014)
TABLE 85 Asia-Pacific modern human insulin market breakdown by type, $m (2015 – 2020)
TABLE 86 Japan human insulin market breakdown by type, $m (2011 – 2014)
TABLE 87 Japan human insulin market breakdown by type, $m (2015 – 2020)
TABLE 88 Japan traditional human insulin market breakdown by type, $m (2011 – 2014)
TABLE 89 Japan traditional human insulin market breakdown by type, $m (2015 – 2020)
TABLE 90 Japan modern human insulin market breakdown by type, $m (2011 – 2014)
TABLE 91 Japan modern human insulin market breakdown by type, $m (2015 – 2020)
TABLE 92 China human insulin market breakdown by type, $m (2011 – 2014)
TABLE 93 China human insulin market breakdown by type, $m (2015 – 2020)
TABLE 94 China traditional human insulin market breakdown by type, $m (2011 – 2014)
TABLE 95 China traditional human insulin market breakdown by type, $m (2015 – 2020)
TABLE 96 China modern human insulin market breakdown by type, $m (2011 – 2014)
TABLE 97 China modern human insulin market breakdown by type, $m (2015 – 2020)
TABLE 98 India human insulin market breakdown by type, $m (2011 – 2014)
TABLE 99 India human insulin market breakdown by type, $m (2015 – 2020)
For more information visit: https://www.psmarketresearch.com/market-analysis/human-insulin-market
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
TABLE 100 India traditional human insulin market breakdown by type, $m (2011 – 2014)
TABLE 101 India traditional human insulin market breakdown by type, $m (2015 – 2020)
TABLE 102 India modern human insulin market breakdown by type, $m (2011 – 2014)
TABLE 103 India modern human insulin market breakdown by type, $m (2015 – 2020)
TABLE 104 Rest of the World human insulin market breakdown by type, $m (2011 – 2014)
TABLE 105 Rest of the World human insulin market breakdown by type, $m (2015 – 2020)
TABLE 106 Rest of the World traditional human insulin market breakdown by type, $m (2011 – 2014)
TABLE 107 Rest of the World traditional human insulin market breakdown by type, $m (2015 – 2020)
TABLE 108 Rest of the World modern human insulin market breakdown by type, $m (2011 – 2014)
TABLE 109 Rest of the World modern human insulin market breakdown by type, $m (2015 – 2020)
TABLE 110 Biocon Ltd.– Key Facts
TABLE 111 TonghuaDongbao Pharmaceuticals Co., Ltd. – Key Facts
TABLE 112 ADOCIA – Key Facts
TABLE 113 Merck & Co. – Key Facts
TABLE 114 Julphar – Key Facts
TABLE 115 Pfizer, Inc.– Key Facts
TABLE 116 Bristol-Myers Squibb Company – Key Facts
TABLE 117 GlaxoSmithKline Plc – Key Facts
TABLE 118 Oramed Pharmaceuticals, Inc. – Key Facts
TABLE 119 Novo Nordisk A/S – Key Facts
TABLE 120 Eli Lilly and Company – Key Facts
TABLE 121 Sanofi – Key Facts
https://www.psmarketresearch.com
Global Human Insulin market is expected to achieve $48,487.7 million value by 2020
About Us
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:
Ms Somya
347, 5th Ave. #1402
New York City, NY - 10016
Email: [email protected]
US/ Canada Toll-Free: 1-888-778-7886
Web: https://www.psmarketresearch.com
https://www.psmarketresearch.com
Top Related